Identifying BRCA1 Variants That May Increase Cancer Risk
Author Information
Author(s): Lovelock Paul K, Spurdle Amanda B, Mok Myth TS, Farrugia Daniel J, Lakhani Sunil R, Healey Sue, Arnold Stephen, Buchanan Daniel, Couch Fergus J, Henderson Beric R, Goldgar David E, Tavtigian Sean V, Chenevix-Trench Georgia, Brown Melissa A
Primary Institution: Queensland Institute of Medical Research
Hypothesis
Can certain BRCA1 missense substitutions be classified as moderate risk variants based on their functional activity?
Conclusion
The study suggests that some BRCA1 variants may be associated with low to moderate cancer risk, highlighting the importance of functional studies in variant classification.
Supporting Evidence
- Functional analyses showed that A1708E and G1738R variants are defective in multiple assays.
- R1699Q and A1708V variants displayed intermediate functional activity.
- Multifactorial likelihood analysis indicated a posterior probability of pathogenicity for A1708E of 99%.
Takeaway
Some changes in the BRCA1 gene might not completely stop it from working, which means people with these changes could still have a chance of getting cancer, but it's not as high as with other changes.
Methodology
The study compared multifactorial likelihood analysis with functional analyses for four BRCA1 variants.
Limitations
The study did not include analysis of tumor loss of heterozygosity, which may limit the assessment of variant pathogenicity.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website